Delivery Order SPE2DB24D2100-SPE2DB25FBAMV

Award Date 10/23/24
Potential Completion Date 10/24/24
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,732.92 and covers the procurement of PEDIARIX 0.5 ML SYRINGE 0.5ML, a pediatric vaccine product. The contract is a firm fixed-price agreement with a period of performance through January 9, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,970.96 Firm Fixed Price Delivery Order contract is for the provision of 0.5 ML PEDIARIX syringes, a pediatric vaccine. The contract has an ultimate completion date of October 17, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,681.24, is a Firm Fixed Price Delivery Order for the supply of 0.5 ML PEDIARIX syringes. The award has an ultimate completion date of February 10, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through...
This federal contract award to Amerisourcebergen Drug Corp (a major pharmaceutical distributor) was issued by the Defense Logistics Agency (DLA) for the delivery of PEDIARIX 0.5 ML SYRINGE 0.5ML, a pediatric vaccine. The $2,361.92 firm fixed-price contract has an ultimate completion date of October 23, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,492.47, is a Firm Fixed Price Delivery Order for the product "PEDIARIX 0.5 ML SYRINGE 0.5ML". The award has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of PEDIARIX 0.5 ML SYRINGE 0.5ML. The contract has a firm fixed price of $4,190.15 and a period of performance through November 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,299.69 firm fixed-price delivery order is for the supply of PEDIARIX 0.5 ML SYRINGE 0.5ML, a pediatric vaccine. The award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract is a Delivery Order worth $5,571.20 for the supply of PEDIARIX 0.5 ML SYRINGE 0.5ML. The contract has a firm fixed price pricing type and an ultimate completion date of March 15, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $53,977.66, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4565832488 PEDIARIX 0.5ML SYR 10S, a pharmaceutical product, with an ultimate completion date of October 15, 2024. This delivery order contract is a firm-fixed-price arrangement and is not set aside for any specific business type. Amerisourcebergen, a major pharmaceutical...
This federal contract award, valued at $4,929.36, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of PEDIARIX 0.5 ML SYRINGE 0.5ML, a pharmaceutical product, with a completion date of May 7, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
  • SPE2DB24D2100
    Indefinite Delivery Contract
  • SPE2DB24D2100-SPE2DB25FBAMV
    Delivery Order

This federal contract award, valued at $1,658.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of PEDIARIX 0.5 ML SYRINGE 0.5ML, a pediatric vaccine product, with an ultimate completion date of October 24, 2024.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

The contract award reviewed was not designated with any set-aside requirements, indicating open competition.

Generated 1/22/25, 9:12 AM